Brief: Pacira Biosciences Files Exparel Patent Infringement Lawsuits Against The Whiteoak Group And Qilu Pharmaceutical

Pacira BioSciences

26/11/2025 21:04

Nov 26 (Reuters) - Pacira Biosciences Inc PCRX.O:

PACIRA BIOSCIENCES FILES EXPAREL® PATENT INFRINGEMENT LAWSUITS AGAINST THE WHITEOAK GROUP AND QILU PHARMACEUTICAL

PACIRA BIOSCIENCES: SEEKS INJUNCTION TO PREVENT MANUFACTURE, USE, SALE OF GENERIC PRODUCTS DESCRIBED IN EACH CO'S ANDA FILED WITH U.S. FDA

PACIRA BIOSCIENCES: LAWSUITS TRIGGERED 30-MONTH STAY OF FINAL FDA APPROVAL OF ANDAS UNDER HATCH WAXMAN ACT

Source text: ID:nGNX8dzT1v

Further company coverage: PCRX.O

 ((Reuters.Briefs@thomsonreuters.com;))